This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Nucleic Acid Delivery: The Contributions of Rebecca McClellan
Introduction
Rebecca McClellan is an accomplished inventor based in Stanford, California. She has made significant contributions to the field of therapeutic delivery systems, particularly focusing on nucleic acid delivery to lung cells. Her innovative work has the potential to enhance the effectiveness of various medical treatments.
Latest Patents
Rebecca McClellan holds a patent for "Immolative cell-penetrating complexes for nucleic acid delivery to the lung." This patent describes complexes, compositions, and methods designed for the delivery of therapeutic, diagnostic, and imaging agents, including nucleic acids, into cells. The technology facilitates the complexation, protection, delivery, and release of oligonucleotides and polyanionic cargos into lung cells and lung tissue, both in vitro and in vivo. She has 1 patent to her name.
Career Highlights
Rebecca is affiliated with Leland Stanford Junior University, where she conducts her research and develops her innovative solutions. Her work is at the intersection of biotechnology and medicine, aiming to improve patient outcomes through advanced delivery mechanisms.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Rebecca McClellan's contributions to nucleic acid delivery systems represent a significant advancement in medical technology. Her innovative approaches have the potential to transform therapeutic practices and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile